The landscape of metabolic management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatide and Retatrutide represent important advancements; Tirzepatid already https://caoimhegjad989743.blogdosaga.com/42930408/the-tirzepatide-this-retatrutide-a-emerging-metabolic-partnership